Master Advancements in mRNA Vaccine Technology in 4 weeks through hands-on, project-based online training with DSTC.
This three-day intensive course dives into the revolutionary world of mRNA vaccine technology, which has shown remarkable success in rapid vaccine development, notably during the COVID-19 pandemic. Participants will explore the fundamental aspects of mRNA vaccine structure, delve into the advanced techniques of vaccine manufacturing, and discuss the future landscape of mRNA technologies in therapeutics and beyond. Every participant receives a verified e-Certificate and e-Marksheet from the Deep Science & Technology Consortium.
This three-day intensive course dives into the revolutionary world of mRNA vaccine technology, which has shown remarkable success in rapid vaccine development, notably during the COVID-19 pandemic. Participants will explore the fundamental aspects of mRNA vaccine structure, delve into the advanced techniques of vaccine manufacturing, and discuss the future landscape of mRNA technologies in therapeutics and beyond.
1. Apply biotechnology methods to authentic research and industry problems.
2. Produce a reproducible, portfolio-ready project you can cite in a thesis, paper, or job application.
β’ Master's and senior undergraduate students specializing in biotechnology
β’ R&D engineers and working professionals applying biotechnology in industry
β’ Academics and educators building research or teaching capacity in biotechnology
β’ Tangible, reproducible biotechnology work to show supervisors or employers.
β’ A verified e-Certificate of competency and e-Marksheet from the Deep Science & Technology Consortium.
β’ Cap, UTRs, coding sequence and poly-A tail and the function of each
β’ Codon optimisation and GC content effects on expression and stability
β’ Nucleoside modification with N1-methylpseudouridine and why it was decisive
β’ IVT reaction, capping strategies and enzymatic against co-transcriptional capping
β’ Double-stranded RNA impurities and their removal as a critical quality step
β’ Purification, fill-finish and the analytical release panel
β’ Ionisable lipid, helper lipid, cholesterol and PEG-lipid roles
β’ Microfluidic formulation and the parameters controlling particle size
β’ Cold chain requirements and the stability work aimed at removing them
β’ Antigen expression, presentation and the resulting T and B cell responses
β’ Innate sensing, reactogenicity and the trade-off against immunogenicity
β’ Durability, waning and the evidence base behind boosting intervals
β’ Self-amplifying and circular mRNA and their claimed dose advantages
β’ Personalised cancer neoantigen vaccines and the manufacturing timeline problem
β’ Protein replacement therapy and the redosing challenge it faces
| Parameter | Requirement |
|---|---|
| Covered Tool / Platform | NCBI Tools |
| Covered Tool / Platform | BLAST |
| Covered Tool / Platform | PyMOL |
| Covered Tool / Platform | AutoDock |
| Covered Tool / Platform | ChemDraw |
| Covered Tool / Platform | Clustal Omega |
| Covered Tool / Platform | Python |
Based on 0 scholar submissions
No verified reviews published yet. Be the first to share your academic experience.
Your rating will help prospective scholars. Ratings below 3 stars are routed privately to the faculty mentor for immediate response.